Hypophosphatemia after iron infusion : can we still ignore it ?
The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasi...
Gespeichert in:
Veröffentlicht in: | Revue médicale suisse 2020-03, Vol.16 (687), p.592-595 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | fre |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 595 |
---|---|
container_issue | 687 |
container_start_page | 592 |
container_title | Revue médicale suisse |
container_volume | 16 |
creator | Scardia, Stefano Bonny, Olivier Favre, Lucie |
description | The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2384215112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2384215112</sourcerecordid><originalsourceid>FETCH-LOGICAL-p563-4b9b7c8509007f8e922b48faf904abbaccefb112c305e1d04475612027038b003</originalsourceid><addsrcrecordid>eNo1j81KAzEYRbNQbKl9BcnSzUD-JpO4ESlqhYKb7ock_WIjM5OYzCDdufFFfRIHrHdzFvdw4V6gJZWSVJo3eoHWpbyTOZJyxvgVWsygkiq-RJvtKcV0jCUdzQh9MNj4ETIOOQ44DH4qIQ4_X9932JkBfwIuY-g6HN6GmAGHca7ur9GlN12B9ZkrtH963G-21e71-WXzsKtSLXklrLaNUzXRhDRegWbMCuWN10QYa41z4C2lzHFSAz0QIZpaUkZYQ7iyhPAVuv2bTTl-TFDGtg_FQdeZAeJUWsaVYLSeJ2b15qxOtodDm3LoTT61_7_5L7f2VCo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2384215112</pqid></control><display><type>article</type><title>Hypophosphatemia after iron infusion : can we still ignore it ?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Scardia, Stefano ; Bonny, Olivier ; Favre, Lucie</creator><creatorcontrib>Scardia, Stefano ; Bonny, Olivier ; Favre, Lucie</creatorcontrib><description>The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.</description><identifier>ISSN: 1660-9379</identifier><identifier>PMID: 32216183</identifier><language>fre</language><publisher>Switzerland</publisher><subject>Administration, Intravenous ; Humans ; Hypophosphatemia - chemically induced ; Hypophosphatemia - prevention & control ; Iron - administration & dosage ; Iron - adverse effects ; Phosphates - metabolism</subject><ispartof>Revue médicale suisse, 2020-03, Vol.16 (687), p.592-595</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32216183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scardia, Stefano</creatorcontrib><creatorcontrib>Bonny, Olivier</creatorcontrib><creatorcontrib>Favre, Lucie</creatorcontrib><title>Hypophosphatemia after iron infusion : can we still ignore it ?</title><title>Revue médicale suisse</title><addtitle>Rev Med Suisse</addtitle><description>The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.</description><subject>Administration, Intravenous</subject><subject>Humans</subject><subject>Hypophosphatemia - chemically induced</subject><subject>Hypophosphatemia - prevention & control</subject><subject>Iron - administration & dosage</subject><subject>Iron - adverse effects</subject><subject>Phosphates - metabolism</subject><issn>1660-9379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KAzEYRbNQbKl9BcnSzUD-JpO4ESlqhYKb7ock_WIjM5OYzCDdufFFfRIHrHdzFvdw4V6gJZWSVJo3eoHWpbyTOZJyxvgVWsygkiq-RJvtKcV0jCUdzQh9MNj4ETIOOQ44DH4qIQ4_X9932JkBfwIuY-g6HN6GmAGHca7ur9GlN12B9ZkrtH963G-21e71-WXzsKtSLXklrLaNUzXRhDRegWbMCuWN10QYa41z4C2lzHFSAz0QIZpaUkZYQ7iyhPAVuv2bTTl-TFDGtg_FQdeZAeJUWsaVYLSeJ2b15qxOtodDm3LoTT61_7_5L7f2VCo</recordid><startdate>20200325</startdate><enddate>20200325</enddate><creator>Scardia, Stefano</creator><creator>Bonny, Olivier</creator><creator>Favre, Lucie</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200325</creationdate><title>Hypophosphatemia after iron infusion : can we still ignore it ?</title><author>Scardia, Stefano ; Bonny, Olivier ; Favre, Lucie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p563-4b9b7c8509007f8e922b48faf904abbaccefb112c305e1d04475612027038b003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2020</creationdate><topic>Administration, Intravenous</topic><topic>Humans</topic><topic>Hypophosphatemia - chemically induced</topic><topic>Hypophosphatemia - prevention & control</topic><topic>Iron - administration & dosage</topic><topic>Iron - adverse effects</topic><topic>Phosphates - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scardia, Stefano</creatorcontrib><creatorcontrib>Bonny, Olivier</creatorcontrib><creatorcontrib>Favre, Lucie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revue médicale suisse</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scardia, Stefano</au><au>Bonny, Olivier</au><au>Favre, Lucie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypophosphatemia after iron infusion : can we still ignore it ?</atitle><jtitle>Revue médicale suisse</jtitle><addtitle>Rev Med Suisse</addtitle><date>2020-03-25</date><risdate>2020</risdate><volume>16</volume><issue>687</issue><spage>592</spage><epage>595</epage><pages>592-595</pages><issn>1660-9379</issn><abstract>The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.</abstract><cop>Switzerland</cop><pmid>32216183</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-9379 |
ispartof | Revue médicale suisse, 2020-03, Vol.16 (687), p.592-595 |
issn | 1660-9379 |
language | fre |
recordid | cdi_proquest_miscellaneous_2384215112 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Administration, Intravenous Humans Hypophosphatemia - chemically induced Hypophosphatemia - prevention & control Iron - administration & dosage Iron - adverse effects Phosphates - metabolism |
title | Hypophosphatemia after iron infusion : can we still ignore it ? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A15%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypophosphatemia%20after%20iron%20infusion%E2%80%85:%20can%20we%20still%20ignore%20it%E2%80%85?&rft.jtitle=Revue%20m%C3%A9dicale%20suisse&rft.au=Scardia,%20Stefano&rft.date=2020-03-25&rft.volume=16&rft.issue=687&rft.spage=592&rft.epage=595&rft.pages=592-595&rft.issn=1660-9379&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2384215112%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2384215112&rft_id=info:pmid/32216183&rfr_iscdi=true |